Mechanism of BMAL1 attenuating H2O2-induced cardiomyocyte injury

doi:10.11958/20231027

Abstract

Abstract:

Objective To investigate the effect of BMAL1 on H₂O₂-induced cardiomyocyte injury through NRF2-regulated ROS/NLRP3 inflammasome pathway. Methods H9c2 cells and H9c2 cells with stable over-expressed BMAL1 were cultured and divided into the control group, the H₂O₂ group, the BMAL1-OE group, the BMAL1-OE+H₂O₂ group, the BMAL1-OE+ML385 group and the BMAL1-OE+ML385+H₂O₂ group. All groups were pre-intervened with corresponding inhibitors, and then treated with 0.2 mmol/L H₂O_2,except for the control group and the BMAL1-OE group. After the intervention, CCK-8 assay was used to measure cell viability, fluorescent probe DCFH-DA was used to measure ROS generation and Western blot assay was used to detect BMAL1, NRF2 and NLRP3 protein expressions. ELISA was used to determine IL-1β release. Results Compared with the control group, the cell viability was decreased, ROS generation was increased, BMAL1 and NRF2 protein expressions were decreased, NLRP3 expression and IL-1β release were increased in the H₂O₂ group (P<0.05). Compared with the H₂O₂ group, the cell viability was increased, ROS generation was decreased, BMAL1-OE and NRF2 protein expressions were increased, NLRP3 expression and IL-1β release were decreased in the BMAL1-OE+H₂O₂ group (P<0.05). Compared with the BMAL1-OE+H₂O₂ group, the cell viability was decreased, ROS generation was increased, NLRP3 expression and IL-1β release were increased in the BMAL1-OE+ML385+H₂O₂ group (P<0.05). Conclusion BMAL1 attenuates H₂O₂-induced H9c2 cardiomyocyte injury, and its mechanism may be related to the regulation of ROS/NLRP3 inflammasome pathway through NRF2.

Key words: ARNTL transcription factors, NF-E2-related factor 2, reactive oxygen species, NLR family, pyrin domain-containing 3 protein, BMAL1, inflammasome

CLC Number:

R542.2

Figures/Tables 6

Tab.1 Comparison of cell viability and ROS production of H9c2 cardiomyocytes between the four groups of part one

组别	n	细胞活力	ROS/%
Control组	6	0.81±0.07	100.90±2.20
H₂O₂组	6	0.38±0.04^a	195.50±12.37^a
BMAL1-OE组	6	0.83±0.06	99.17±1.89
BMAL1-OE+H₂O₂组	6	0.64±0.05^b	143.50±6.12^b
F		79.290^＊＊	248.700^＊＊

Fig.1 NRF2 and NLRP3 protein expression of H9c2 cardiomyocytes in each group of part one

Fig.2 IL-1β release of H9c2 cardiomyocytes in each group of part one

Tab.2 Comparison of cell viability and ROS production of H9c2 cardiomyocytes between the four groups of part two

组别	n	细胞活力	ROS/%
BMAL1-OE组	6	0.91±0.06	101.80±4.98
BMAL1-OE+H₂O₂组	6	0.65±0.04^a	142.30±10.34^a
BMAL1-OE+ML385组	6	0.87±0.07	100.70±2.42
BMAL1-OE+ML385+H₂O₂组	6	0.53±0.07^b	168.90±8.64^b
F		56.170^＊＊	124.900^＊＊

Fig.3 NLRP3 protein expression of H9c2 cardiomyocytes in each group of part two

Fig.4 IL-1β release of H9c2 cardiomyocytes in each group of part two

References 20

[1]	中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2020概要[J]. 中国循环杂志, 2021, 36(6):521-545.
	The Writing Committee of the Report on Cardiovascular Health and Diseases in China. Report on cardiovascular health and diseases burden in china:an updated summary of 2020[J]. Chin Circ J, 2021, 36(6):521-545. doi:10.3969/j.issn.1000-3614.2021.06.001.
[2]	赵冬. 心血管疾病危险因素的研究:过去、现在和未来[J]. 中国循环杂志, 2021, 36(1):1-3.
	ZHAO D. Research on cardiovascular disease risk factors:past,present and future[J]. Chin Circ J, 2021, 36(1):1-3. doi:10.3969/j.issn.1000-3614.2021.01.001.
[3]	PELLEGRINI C, MARTELLI A, ANTONIOLI L, et al. NLRP3 inflammasome in cardiovascular diseases:Pathophysiological and pharmacological implications[J]. Med Res Rev, 2021, 41(4):1890-1926. doi:10.1002/med.21781.
[4]	谭红梅. NLRP3炎症小体与心血管疾病[J]. 中山大学学报(医学科学版), 2017, 38(2):215-221.
	TAN H M. Role of NLRP3 inflammasome in cardiovascular diseases[J]. J Sun Yat-sen Univ (Med Sci), 2017, 38(2):215-221. doi:10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2017.0035.
[5]	THOSAR S S, BUTLER M P, SHEA S A. Role of the circadian system in cardiovascular disease[J]. J Clin Invest, 2018, 128(6):2157-2167. doi:10.1172/JCI80590.
[6]	易娜, 袁李礼. BMAL1对H₂O₂诱导的H9c2心肌细胞损伤的影响及机制探讨[J]. 天津医药, 2021, 49(8):791-795.
	YI N, YUAN L L. Effects and mechanism of BMAL1 on H₂O₂-induced H9C2 cardiomyocyte injury[J]. Tianjin Med J, 2021, 49(8):791-795. doi:10.11958/20210463.
[7]	杨瑾, 徐志峰, 苏嘉, 等. 生物钟基因与心血管疾病的研究进展[J]. 中华心血管病杂志, 2020, 48(7):610-615.
	YANG J, XU Z F, SU J, et al. Research progress on the circadian clock regulation in cardiovascular system and associationbetween circadian clock regulation and cardiovascular diseases[J]. Chin J Cardiol, 2020, 48(7):610-615. doi:10.3760/cma.j.cn112148-20190725-00430.
[8]	易娜, 李贺, 游三丽, 等. 丹参酮ⅡA通过AK003290减轻H₂O₂诱导的原代小鼠心肌细胞焦亡[J]. 中国病理生理杂志, 2021, 37(6):1035-1041.
	YI N, LI H, YOU S L, et al. Tanshinone IIA attenuates H₂O₂-induced primary mouse cardiomyocyte pyroptosis via AK003290[J]. Chin J Pathophysiol, 2021, 37(6):1035-1041. doi:10.11958/20210463.
[9]	ABBATE A, TOLDO S, MARCHETTI C, et al. Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease[J]. Circ Res, 2020, 126(9):1260-1280.
[10]	PANDEY A, SHEN C, FENG S, et al. Cell biology of inflammasome activation[J]. Trends Cell Biol, 2021, 31(11):924-939. doi:10.1016/j.tcb.2021.06.010.
[11]	ZHAO T, WU W, SUI L, et al. Reactive oxygen species-based nanomaterials for the treatment of myocardial ischemia reperfusion injuries[J]. Bioact Mater, 2021, 7:47-72. doi:10.1016/j.bioactmat.2021.06.006.
[12]	王佳慧, 梁欢, 方典, 等. 抑制线粒体活性氧自由基可减轻高糖诱导的心肌细胞焦亡和铁死亡[J]. 南方医科大学学报, 2021, 41(7):980-987.
	WANG J H, LIANG H, FANG D, et al. Inhibition of mitochondrial reactive oxygen species reduces high glucose-induced pyroptosis and ferroptosis in H9C2 cardiac myocytes[J]. J South Med Univ, 2021, 41(7):980-987. doi:10.12122/j.issn.1673-4254.2021.07.03.
[13]	WEI Z, NIE G, YANG F, et al. Inhibition of ROS/NLRP3/Caspase-1 mediated pyroptosis attenuates cadmium-induced apoptosis in duck renal tubular epithelial cells[J]. Environ Pollut, 2020, 273:115919. doi:10.1016/j.envpol.2020.115919.
[14]	HONG H, CHEUNG Y M, CAO X, et al. REV-ERBα agonist SR9009 suppresses IL-1β production in macrophages through BMAL1-dependent inhibition of inflammasome[J]. Biochem Pharmacol, 2021, 192:114701. doi:10.1016/j.bcp.2021.114701.
[15]	SIES H, JONES D P. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents[J]. Nat Rev Mol Cell Biol, 2020, 21(7):363-383. doi:10.1038/s41580-020-0230-3.
[16]	KASAI S, SHIMIZU S, TATARA Y, et al. Regulation of Nrf2 by mitochondrial reactive oxygen species in physiology and pathology[J]. Biomolecules, 2020, 10(2):320. doi:10.3390/biom10020320.
[17]	陈芳, 邹联洪, 刘协红, 等. NRF2减轻阿霉素诱导的心肌H9c2细胞氧化应激和溶酶体功能障碍[J]. 中国病理生理杂志, 2019, 35(8):1359-1364.
	CHEN F, ZOU L H, LIU X H, et al. NRF2 attenuates oxidative stress and lysosomal dysfunction in doxorubicin-induced H9C2 cells[J]. Chin J Pathophysiol, 2019, 35(8):1359-1364. doi:10.3969/j.issn.1000-4718.2019.08.003.
[18]	CHHUNCHHA B, KUBO E, SINGH D P. Clock protein BMAL1 and Nrf2 cooperatively control aging or oxidative response and redox homeostasis by regulating rhythmic expression of prdx6[J]. Cells, 2020, 9(8):1861. doi:10.3390/cells9081861.
[19]	LIU X H, XIAO W, JIANG Y, et al. BMAL1 regulates the redox rhythm of HSPB1,and homooxidized HSPB1 attenuates the oxidative stress injury of cardiomyocytes[J]. Oxid Med Cell Longev, 2021, 2021:5542815. doi:10.1155/2021/5542815.
[20]	EARLY J O, MENON D, WYSE C A, et al. Circadian clock protein BMAL1 regulates IL-1β in macrophages via NRF₂[J]. Proc Natl Acad Sci USA, 2018, 115(36):E8460-E8468. doi:10.1073/pnas.1800431115.

Mechanism of BMAL1 attenuating H₂O₂-induced cardiomyocyte injury

Cite this article

RichHTML

PDF (PC)

Knowledge

Abstract

share this article

Figures/Tables 6

References 20

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	FU Nannan, LIU Tao, LI Juan, ZHAO Yu. Regulative effect of tripterine on oxidative stress and senescence in hepatocellular carcinoma cells [J]. Tianjin Medical Journal, 2026, 54(7): 681-686.
[2]	ZHOU Yuke, SUN Wei, GAO Qing, HE Jun. The effect of sevoflurane on neuronal inflammation in rats with spinal cord injury by regulating the ROS/TXNIP/NLRP3 pathway [J]. Tianjin Medical Journal, 2025, 53(9): 910-915.
[3]	LIU Haiwei, YANG Jie, WANG Li, MENG Shibo, TANG Xusong, LIU Chengren, WANG Yongwang. Luteolin inhibits glioblastoma by regulating ROS levels via the NFE2L2/x-CT/GPX4 signalling axis [J]. Tianjin Medical Journal, 2025, 53(7): 673-678.
[4]	LI Min, GONG Jian, WU Weiwei, LIU Qiao. Research progress on the role of Nrf2/HO-1 pathway in psoriasis [J]. Tianjin Medical Journal, 2024, 52(5): 552-556.
[5]	XIANG Jinjie, LYU Maoxin, WANG Mengyue, ZHANG Kun, LI Hao. Molecular mechanisms of Ca²⁺-induced pyroptosis and adhesion changes of HK-2 cells in the formation of calcium-containing kidney stones [J]. Tianjin Medical Journal, 2024, 52(3): 250-255.
[6]	CHEN Jing, WEI Yunjiao, LUO Chao, HUANG Lihua, CHEN Cheng, DUAN Shasha. The mechanism of Wumei pill on ulcerative colitis in mice based on Nrf2/ARE antioxidant stress pathway [J]. Tianjin Medical Journal, 2024, 52(3): 278-254.
[7]	LI Yanping, WANG Xietao, SHI Libin, LIU Qiong. Influence of resveratrol on H₂O₂-induced ferroptosis in alveolar epithelial cells by regulating the Nrf2-GPX4 pathway [J]. Tianjin Medical Journal, 2023, 51(6): 568-572.
[8]	LI Qiuchang, YAN Shunchang, MENG Yazhen, GU Yunxia, NING Qiaoming, LI Na, WANG Zhihua. Neuroprotective effects of dexmedetomidine on intracerebral hemorrhage of rats by Nrf2-GPX4 mediated iron death pathway [J]. Tianjin Medical Journal, 2022, 50(8): 817-821.
[9]	CHEN Lixu, XIONG Jia, XIE Kun, ZHU Tingde, ZHONG Zhiying, GUAN Liang, PAN Yongping. Study on the mechanism of Fuzheng Huayu prescription drug-containing serum affecting the activation of activinA/smad signaling pathway in hepatic stellate cells [J]. Tianjin Medical Journal, 2022, 50(7): 707-712.
[10]	CHEN Yu, SU Jianjun, HAN Yun, LI Ying, ZHANG Lunmin, YANG Yi, HUANG Bo△. Study on the protective effect of dimethyl fumarate on myocardial ischemia/reperfusion injury by regulating the iron death pathway mediated by Nrf2-GPX4 in rats [J]. Tianjin Medical Journal, 2022, 50(6): 601-607.
[11]	HOU Wanmei, GUAN Jinfan, LIU Bingyuan, LIN Dongrong, ZHAO Yuanyu, ZHANG Juanzi, HAN Jiangquan. The role of Nrf2 in regulating AIM2 inflammation in cerebral ischemia reperfusion injury in rats [J]. Tianjin Medical Journal, 2022, 50(4): 368-374.
[12]	ZHAI Xinxiang, DONG Hui, WANG Jing, WANG Yongxiang. Study on the protective mechanism of astragalus polysaccharides on functional activity of osteoblasts in ovariectomy rats [J]. Tianjin Medical Journal, 2022, 50(3): 265-269.
[13]	CHEN Li, MA Yali, LI Benliang. The effects of exogenous hydrogen sulfide on cognitive function and intestinal barrier function through Nrf2/ARE/HO-1 pathway in schizophrenic rats [J]. Tianjin Medical Journal, 2022, 50(2): 143-149.
[14]	HE Jing, SUN Xiaohui, YANG Li, WU Yuliang . Secretory clusterin attenuated hydrogen peroxide induced cardiomyocyte injury by inhibiting mitophagy #br# [J]. Tianjin Medical Journal, 2022, 50(2): 136-142.
[15]	DONG Chao, LI Huayu, OU Haojie, SUN Jia, ZHANG Luyong, LIU Bing△. Fenofibrate improves acute lung injury induced by lipopolysaccharide [J]. Tianjin Medical Journal, 2022, 50(1): 59-66.